siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells
Open Access
- 25 January 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 17 (10), 1436-1445
- https://doi.org/10.1093/hmg/ddn032
Abstract
Most cases of the dominantly inherited movement disorder, early onset torsion dystonia (DYT1) are caused by a mutant form of torsinA lacking a glutamic acid residue in the C-terminal region (torsinAΔE). TorsinA is an AAA+ protein located predominantly in the lumen of the endoplasmic reticulum (ER) and nuclear envelope apparently involved in membrane structure/movement and processing of proteins through the secretory pathway. A reporter protein Gaussia luciferase (Gluc) shows a reduced rate of secretion in primary fibroblasts from DYT1 patients expressing endogenous levels of torsinA and torsinAΔE when compared with control fibroblasts expressing only torsinA. In this study, small interfering RNA (siRNA) oligonucleotides were identified, which downregulate the levels of torsinA or torsinAΔE mRNA and protein by over 65% following transfection. Transfection of siRNA for torsinA message in control fibroblasts expressing Gluc reduced levels of luciferase secretion compared with the same cells non-transfected or transfected with a non-specific siRNA. Transfection of siRNA selectively inhibiting torsinAΔE message in DYT fibroblasts increased luciferase secretion when compared with cells non-transfected or transfected with a non-specific siRNA. Further, transduction of DYT1 cells with a lentivirus vector expressing torsinA, but not torsinB, also increased secretion. These studies are consistent with a role for torsinA as an ER chaperone affecting processing of proteins through the secretory pathway and indicate that torsinAΔE acts to inhibit this torsinA activity. The ability of allele-specific siRNA for torsinAΔE to normalize secretory function in DYT1 patient cells supports its potential role as a therapeutic agent in early onset torsion dystonia.Keywords
This publication has 57 references indexed in Scilit:
- Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficitsProceedings of the National Academy of Sciences of the United States of America, 2007
- A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER StressPLOS ONE, 2007
- Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- A Single siRNA Suppresses Fatal Encephalitis Induced by Two Different FlavivirusesPLoS Medicine, 2006
- AAA+ proteins: have engine, will workNature Reviews Molecular Cell Biology, 2005
- An improved cyan fluorescent protein variant useful for FRETNature Biotechnology, 2004
- Recombinant Expression, Purification, and Comparative Characterization of TorsinA and Its Torsion Dystonia-Associated Variant ΔE-TorsinABiochemistry, 2003
- The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding proteinNature Genetics, 1997
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970